LINCOLN PHARMACEUTICALS LTD. | Scrip Code : 531633 | Quarter ending :September 2016 |
| Declaration
| |
|
|
Whether the Listed Entity has issued any partly paid up shares? | No | Whether the Listed Entity has issued any Convertible Securities ? | No | Whether the Listed Entity has issued any Warrants ? | Yes | Whether the Listed Entity has any shares against which depository receipts are issued? | No | Whether the Listed Entity has any shares in locked-in? | Yes | Whether any shares held by promoters are pledge or otherwise encumbered? | No | Whether company has equity shares with differential voting rights? | No |
| Summary statement holding of specified securities
| |
|
|
(A) Promoter & Promoter Group | 32 | 58,36,615 | 58,36,615 | 35.78 | 58,36,615 | 35.78 | 8,00,000 | 33.18 | 8,60,600 | 14.74 | 58,36,615 | - | - | - | (B) Public | 14,740 | 1,04,74,185 | 1,04,74,185 | 64.22 | 1,04,74,185 | 64.22 | 28,89,200 | 66.82 | 25,000 | 0.24 | 1,02,87,475 | - | - | - | (C1) Shares underlying DRs | | | | 0.00 | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C2) Shares held by Employee Trust | | | | 0.00 | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C) Non Promoter-Non Public | | | | 0.00 | | 0.00 | | 0.00 | | 0.00 | | - | - | - | Grand Total | 14,772 | 1,63,10,800 | 1,63,10,800 | 100.00 | 1,63,10,800 | 100.00 | 36,89,200 | 100.00 | 8,85,600 | 5.43 | 1,61,24,090 | - | - | - |
| Note:C=C1+C2 Grand Total=A+B+C
|